GSK Menquadfi Meningococcal Vaccine from United States
Menquadfi is a quadrivalent meningococcal conjugate vaccine protecting against serogroups A, C, W, and Y. It is packaged in prefilled syringes for retail sale, qualifying as an immunological product under tariff item 3002.15.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the vaccine is registered with Health Canada and has a valid DIN
• Declare the product as an immunological product in measured doses for retail sale
• Keep the product inserts and batch certificates ready for CBSA review